BACKGROUND: Along with efficacy, a microbicide's acceptability will be integral to its impact on the pandemic. Understanding Product Characteristics that users find most acceptable and determining who will use which type of product are key to optimizing use effectiveness. OBJECTIVES: To evaluate psychometrically the Important Microbicide Characteristics (IMC) instrument and examine its relationship to willingness to use microbicides. RESULTS: Exploratory and confirmatory factor analyses revealed 2 IMC subscales (Cronbach's coefficient alpha: Product Characteristics subscale (alpha = 0.84) and Protective Properties subscale (alpha = 0.89)). Significant differences on Product Characteristics subscale scores were found for history of douching (P = 0.002) and employment status (P = 0.001). Whether a woman used a method to prevent pregnancy or sexually transmitted disease (STD) in the last 3 months (P < 0.001) and whether she used a condom during the last vaginal sex episode (P < 0.001) were significantly related to her rating of the importance of microbicides being contraceptive. Product Characteristics (r = 0.21) and Protective Properties (r = 0.27) subscale scores and whether a microbicide had contraceptive properties (r = 0.24) were all significantly associated (P < 0.001) with willingness to use microbicides. CONCLUSIONS: Formulation and use characteristics and product function(s) affect willingness to use microbicides and should continue to be addressed in product development. The IMC instrument serves as a template for future studies of candidate microbicides.
BACKGROUND: Along with efficacy, a microbicide's acceptability will be integral to its impact on the pandemic. Understanding Product Characteristics that users find most acceptable and determining who will use which type of product are key to optimizing use effectiveness. OBJECTIVES: To evaluate psychometrically the Important Microbicide Characteristics (IMC) instrument and examine its relationship to willingness to use microbicides. RESULTS: Exploratory and confirmatory factor analyses revealed 2 IMC subscales (Cronbach's coefficient alpha: Product Characteristics subscale (alpha = 0.84) and Protective Properties subscale (alpha = 0.89)). Significant differences on Product Characteristics subscale scores were found for history of douching (P = 0.002) and employment status (P = 0.001). Whether a woman used a method to prevent pregnancy or sexually transmitted disease (STD) in the last 3 months (P < 0.001) and whether she used a condom during the last vaginal sex episode (P < 0.001) were significantly related to her rating of the importance of microbicides being contraceptive. Product Characteristics (r = 0.21) and Protective Properties (r = 0.27) subscale scores and whether a microbicide had contraceptive properties (r = 0.24) were all significantly associated (P < 0.001) with willingness to use microbicides. CONCLUSIONS: Formulation and use characteristics and product function(s) affect willingness to use microbicides and should continue to be addressed in product development. The IMC instrument serves as a template for future studies of candidate microbicides.
Authors: K J Sikkema; T G Heckman; J A Kelly; E S Anderson; R A Winett; L J Solomon; D A Wagstaff; R A Roffman; M J Perry; V Cargill; D A Crumble; R W Fuqua; A D Norman; M B Mercer Journal: Am J Public Health Date: 1996-08 Impact factor: 9.308
Authors: Kenneth H Mayer; Salim Abdool Karim; Clifton Kelly; Lisa Maslankowski; Helen Rees; Albert T Profy; Jennifer Day; Julie Welch; Zeda Rosenberg Journal: AIDS Date: 2003-02-14 Impact factor: 4.177
Authors: Kathleen Morrow; Rochelle Rosen; Linda Richter; Anne Emans; Anna Forbes; Jennifer Day; Neetha Morar; Lisa Maslankowski; Albert T Profy; Cliff Kelly; Salim S Abdool Karim; Kenneth H Mayer Journal: J Womens Health (Larchmt) Date: 2003-09 Impact factor: 2.681
Authors: Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz Journal: AIDS Res Hum Retroviruses Date: 2013-12-09 Impact factor: 2.205
Authors: Kathleen M Morrow; Kristen Underhill; Jacob J van den Berg; Sara Vargas; Rochelle K Rosen; David F Katz Journal: Arch Sex Behav Date: 2014-01-23
Authors: Joseph L Fava; Jacob J van den Berg; Rochelle K Rosen; Liz Salomon; Sara Vargas; Anna L Christensen; Megan Pinkston; Kathleen M Morrow Journal: Sex Health Date: 2013-08 Impact factor: 2.706
Authors: Kathleen M Morrow; Rochelle K Rosen; Liz Salomon; Cynthia Woodsong; Lawrence Severy; Joseph L Fava; Sara Vargas; Candelaria Barroso Journal: Qual Health Res Date: 2011-03-29
Authors: Sara E Vargas; Joseph L Fava; Lawrence Severy; Rochelle K Rosen; Liz Salomon; Lawrence Shulman; Kate Morrow Guthrie Journal: Arch Sex Behav Date: 2015-11-30
Authors: Andrea Ries Thurman; Alan E C Holden; Rochelle N Shain; Sondra Perdue; Jeanna M Piper Journal: Sex Transm Dis Date: 2009-06 Impact factor: 2.830